Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
about
Role of Probiotics in health improvement, infection control and disease treatment and managementCommensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cellsEffects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes.Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model.An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum.Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activationModulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics.Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitro.Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Secreted factors from Bifidobacterium animalis subsp. lactis inhibit NF-κB-mediated interleukin-8 gene expression in Caco-2 cells.Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis.Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged miceAn In Vitro Approach to Study Effects of Prebiotics and Probiotics on the Faecal Microbiota and Selected Immune Parameters Relevant to the ElderlyCharacterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells.A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003.Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitisEvidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach.Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.Innate immunity and inflammatory bowel disease: a review of clinical evidence and future application.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Effects of phytochemicals on in vitro anti-inflammatory activity of Bifidobacterium adolescentis.Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin.Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants.Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression.Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection.Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.Functional properties of anti-inflammatory substances from quercetin-treated Bifidobacterium adolescentis.Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486.Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells.In vitrodifferential modulation of immune response by probiotics in porcine peripheral blood mononuclear cells
P2860
Q27008261-DBBBE25E-3C10-4ECE-97A1-768BEB6001F2Q33427772-6F289F9E-8D70-4091-9B57-F886A2A5229BQ33890323-E8BD39CE-C70A-4294-8A4B-88FAAAED0169Q33901112-57C5AB0E-0845-4624-8C13-37412EA66FD2Q34060471-BF88ADE8-C83E-4CF0-A153-7A81C4AD5533Q34297879-6B2B5672-6385-4EF9-883B-B918EFC4796DQ34384871-3D7E2204-709A-42E3-BE7C-542E03BCAFD4Q34499067-616D948A-C8E3-46CE-A1BF-31C1217F92A8Q34626740-E17D1BB6-4D9A-47EB-8EF7-5447C62426F8Q35035752-348025C1-615C-4D84-A763-5535A4A4DEF9Q35195891-80E4FBC2-7772-4B50-BAF3-7449D21BC8E2Q35530138-E71DD318-C602-49B5-9EA7-8B52F883F5FEQ35780928-059BCD26-C1C5-4208-9BB9-AA0D50E754A9Q35994281-126CAF62-D83A-4F03-BAEC-82FE413B32D5Q36128689-01A801B7-21CC-4522-8621-1AF80D4F94A5Q36166571-C75FB45A-7FF5-4133-996C-A8512F1EB7FFQ36277139-B7472A76-C340-4DFA-A68A-DF9374D69DBAQ37118873-4039DB8D-12F3-4722-BD34-FAA51C56CD9DQ37851431-2328E520-5C8E-4E8F-937C-5F06F3F0CA7FQ38253720-72E78F43-28BC-442D-9023-160BB3E9741CQ38374202-4FDEF46B-66FC-4E69-BC73-0CB6487D9876Q38548567-6F34A5D3-F42C-46CC-97C3-97F3223F8481Q38794312-8F1EF6B4-043C-4804-97ED-19BAAEA08DA4Q38905606-9B855E99-F531-4D24-B312-CF842583CB5AQ39171816-E321FEF1-EB03-45FE-AB12-E3B13A030699Q39450357-62F087C3-A964-40A1-B23B-4146AFC86E93Q39866028-CEDC14E0-0B11-476F-922A-8DC697FC28C2Q42580341-40CED462-D16C-495A-95CA-12E7C34727DBQ44410046-F8BBD1BC-3A8C-4ECB-8D4A-F342B3AAA768Q46242554-25DA7336-0CA9-4219-9B2C-BC75CA7AD5F0Q46256251-918FAC2F-93E7-415E-8A6D-BF00906B2F4BQ48262909-B479AE82-EB24-4D8A-BEDE-13E8D3FB22D5Q49948526-AC3BB379-5290-4358-8F08-5EF2812916F3Q51352921-D5F85740-FA05-4583-B2D4-1CACD3A54095Q54295984-3EFEBA2D-D060-4E8A-803F-8448779D4415Q58327085-6E3FA005-2B75-4F32-A7B2-3CDDBCBE6B1A
P2860
Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@en
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@nl
type
label
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@en
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@nl
prefLabel
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@en
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@nl
P2093
P2860
P921
P356
P1476
Anti-inflammatory activity of ...... IL-8 secretion in HT-29 cells.
@en
P2093
Akemi Imaoka
Hiromi Setoyama
Kimitoshi Kato
Satoshi Matsumoto
Shigeaki Mizuno
Taeko Hara
Tatsuichiro Shima
Toshiki Uehara
Yoshinori Umesaki
P2860
P304
P356
10.3748/WJG.14.2511
P407
P577
2008-04-01T00:00:00Z